Loading stock analysis…
Evidence Synthesis
Last synthesized: 22 Jul 2026, 16:26
Evidence Synthesis
RELIABVEN's 87.07% gross margin accelerated to, up from -388.89%.
The company's .89% marginal operating leverage decelerated, down from -284.92%. RELIABVEN's daily volume decreased to 2,062 shares, down from 25,583 shares. The company's .32 INR close price decelerated, down from 24.41 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 87.07 % | -388.89 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -388.89 % | -284.92 | ▼ |
| REVENUE_GROWTH_YOY | -60.6 % | — | - |
| PRICE_CHANGE_PERCENT | -0.369 % | — | - |
| DAILY_VOLUME | 2,062 shares | 25,583 | ▼ |
| CLOSE_PRICE | 24.32 INR | 24.41 | ▼ |